Arsenic Toxicity: Molecular Targets and Therapeutic Agents

Valeria M. Nurchi,Aleksandra Buha Djordjevic,Guido Crisponi,Jan Alexander,Geir Bjørklund,Jan Aaseth
DOI: https://doi.org/10.3390/biom10020235
IF: 6.064
2020-02-04
Biomolecules
Abstract:High arsenic (As) levels in food and drinking water, or under some occupational conditions, can precipitate chronic toxicity and in some cases cancer. Millions of people are exposed to unacceptable amounts of As through drinking water and food. Highly exposed individuals may develop acute, subacute, or chronic signs of poisoning, characterized by skin lesions, cardiovascular symptoms, and in some cases, multi-organ failure. Inorganic arsenite(III) and organic arsenicals with the general formula R-As2+ are bound tightly to thiol groups, particularly to vicinal dithiols such as dihydrolipoic acid (DHLA), which together with some seleno-enzymes constitute vulnerable targets for the toxic action of As. In addition, R-As2+-compounds have even higher affinity to selenol groups, e.g., in thioredoxin reductase that also possesses a thiol group vicinal to the selenol. Inhibition of this and other ROS scavenging seleno-enzymes explain the oxidative stress associated with arsenic poisoning. The development of chelating agents, such as the dithiols BAL (dimercaptopropanol), DMPS (dimercapto-propanesulfonate) and DMSA (dimercaptosuccinic acid), took advantage of the fact that As had high affinity towards vicinal dithiols. Primary prevention by reducing exposure of the millions of people exposed to unacceptable As levels should be the prioritized strategy. However, in acute and subacute and even some cases with chronic As poisonings chelation treatment with therapeutic dithiols, in particular DMPS appears promising as regards alleviation of symptoms. In acute cases, initial treatment with BAL combined with DMPS should be considered.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problems that this paper attempts to solve are the impact of arsenic (As) toxicity on human health and its molecular targets, as well as effective treatment methods for arsenic poisoning. Specifically, the paper focuses on the following aspects: 1. **Environmental sources**: It explores the sources of arsenic exposure in drinking water, food, and occupational environments, especially in high - risk areas. 2. **Health hazards**: It describes in detail the symptoms of acute, sub - acute, and chronic arsenic poisoning, including skin lesions, cardiovascular symptoms, and even multi - organ failure. In addition, it also discusses the relationship between arsenic and various cancers (such as lung cancer, bladder cancer, and skin cancer). 3. **Molecular targets**: It analyzes the molecular mechanisms of arsenic toxicity, especially how arsenic compounds bind to thiol groups (such as dihydrolipoic acid) and selenol groups, leading to oxidative stress and cell damage. 4. **Treatment measures**: It reviews the chelating agents currently used to treat arsenic poisoning, such as BAL (dimercaprol), DMPS (sodium dimercaptopropanesulfonate), and DMSA (dimercaptosuccinic acid), and discusses their efficacy and methods of use. Through research in these aspects, the paper aims to provide a comprehensive review to help readers understand the complexity of arsenic toxicity and provide a scientific basis for the prevention and treatment of arsenic poisoning.